isoniazid and debrisoquin

isoniazid has been researched along with debrisoquin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (42.86)	18.7374
1990's	1 (14.29)	18.2507
2000's	2 (28.57)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Clark, DW	1
Aberg-Wistedt, A; Bertilsson, L; Dumont, E; Lundström, J	1
Jack, DB	1
Alda, O; Bartolome, M; Benítez, J; Bernal, ML; Lanuza, J; Rueda, P; Saenz, MA; Sinués, B; Tres, A	1

Reviews

1 review(s) available for isoniazid and debrisoquin

Article	Year
Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs, 1985, Volume: 29, Issue:4 Topics: Acetylation; Anticonvulsants; Antidepressive Agents, Tricyclic; Debrisoquin; Disease; Drug Interactions; Genetic Variation; Humans; Hydralazine; Isoniazid; Oxidation-Reduction; Pharmaceutical Preparations; Phenelzine; Phenotype; Procainamide; Racial Groups; Sparteine; Sulfasalazine	1985

Article

Year

Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Drugs, 1985, Volume: 29, Issue:4

Topics: Acetylation; Anticonvulsants; Antidepressive Agents, Tricyclic; Debrisoquin; Disease; Drug Interactions; Genetic Variation; Humans; Hydralazine; Isoniazid; Oxidation-Reduction; Pharmaceutical Preparations; Phenelzine; Phenotype; Procainamide; Racial Groups; Sparteine; Sulfasalazine

1985

Other Studies

6 other study(ies) available for isoniazid and debrisoquin

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Rapid conjugation in an extremely rapid hydroxylator of debrisoquine: a case report supporting a coregulation of certain phase I and II metabolic reactions. Therapeutic drug monitoring, 1988, Volume: 10, Issue:2 Topics: Adult; Antidepressive Agents; Debrisoquin; Desipramine; Female; Glucuronates; Humans; Hydroxylation; In Vitro Techniques; Isoniazid; Isoquinolines; Oxazepam; Zimeldine	1988
Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution. European journal of clinical pharmacology, 1983, Volume: 25, Issue:4 Topics: Acebutolol; Africa; Debrisoquin; Humans; Isoniazid; Metoprolol; Polymorphism, Genetic; Sparteine; Statistics as Topic	1983
Thioether excretion, urinary mutagenicity, and metabolic phenotype in smokers. Journal of toxicology and environmental health, 1994, Volume: 43, Issue:3 Topics: Acetylation; Adult; Biomarkers; Creatinine; Debrisoquin; Female; Genetic Predisposition to Disease; Humans; Hydroxylation; Isoniazid; Male; Mutagenicity Tests; Mutagens; Neoplasms; Phenotype; Smoking; Sulfides	1994